当前位置:首页 - 行情中心 - 晨光生物(300138) - 财务分析 - 现金流量表

晨光生物

(300138)

  

流通市值:52.30亿  总市值:63.43亿
流通股本:3.98亿   总股本:4.83亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金5,567,470,629.343,460,143,662.691,867,794,372.087,452,744,440.47
  收到的税费返还95,626,814.362,372,162.121,668,911.38110,500,140.59
  收到其他与经营活动有关的现金189,743,655.2865,421,183.8134,913,541.85236,827,579.41
  经营活动现金流入小计5,852,841,098.983,527,937,008.621,904,376,825.317,800,072,160.47
  购买商品、接受劳务支付的现金3,026,407,187.591,964,157,829.291,448,224,402.317,042,998,295.6
  支付给职工以及为职工支付的现金216,190,905.7140,850,033.5669,898,876.43265,016,266.31
  支付的各项税费97,158,417.8774,599,197.734,262,468.37102,134,495.2
  支付其他与经营活动有关的现金158,600,499.38130,347,709.0175,130,399.52177,016,134.37
  经营活动现金流出小计3,498,357,010.542,309,954,769.561,627,516,146.637,587,165,191.48
  经营活动产生的现金流量净额2,354,484,088.441,217,982,239.06276,860,678.68212,906,968.99
二、投资活动产生的现金流量:
  收回投资收到的现金2,981,521,735.31,325,187,112.3663,253,377.8820,497,306
  取得投资收益收到的现金36,314,820.821,883,175.951,577,267.8869,519,259.98
  处置固定资产、无形资产和其他长期资产收回的现金净额3,138,871.833,138,871.8318,1094,481,838
  处置子公司及其他营业单位收到的现金净额----277,970.65
  投资活动现金流入小计3,020,975,427.931,350,209,160.08664,848,754.68894,220,433.33
  购建固定资产、无形资产和其他长期资产支付的现金112,261,707.2960,260,888.4225,987,217.95135,256,502.92
  投资支付的现金3,115,449,187.92,296,491,517.91,880,543,455.3767,461,886.56
  投资活动现金流出小计3,227,710,895.192,356,752,406.321,906,530,673.25902,718,389.48
  投资活动产生的现金流量净额-206,735,467.26-1,006,543,246.24-1,241,681,918.57-8,497,956.15
三、筹资活动产生的现金流量:
  取得借款收到的现金3,687,638,345.442,723,642,345.442,114,997,315.445,975,814,035.9
  收到其他与筹资活动有关的现金30,150,00030,150,000-20,620,000
  筹资活动现金流入小计3,717,788,345.442,753,792,345.442,114,997,315.445,996,434,035.9
  偿还债务支付的现金4,381,442,0002,528,204,000.01620,600,0005,766,417,225.16
  分配股利、利润或偿付利息支付的现金227,951,689.16207,235,775.8631,881,963.94159,853,624.51
  支付其他与筹资活动有关的现金123,294,070.9160,000,137.6760,207,160711,004
  筹资活动现金流出小计4,732,687,760.072,795,439,913.54712,689,123.945,926,981,853.67
  筹资活动产生的现金流量净额-1,014,899,414.63-41,647,568.11,402,308,191.569,452,182.23
四、汇率变动对现金及现金等价物的影响2,106,860.872,766,664.791,217,453.22-3,622,724.59
五、现金及现金等价物净增加额1,134,956,067.42172,558,089.51438,704,404.83270,238,470.48
  加:期初现金及现金等价物余额785,040,710.5785,040,710.5785,040,710.5514,802,240.02
  期末现金及现金等价物余额1,919,996,777.92957,598,800.011,223,745,115.33785,040,710.5
补充资料:
  净利润-184,286,276.37-374,875,475.85
  资产减值准备-6,086,379.22-39,220,328.62
  固定资产和投资性房地产折旧-82,576,600.2-173,626,497.04
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-82,576,600.2-173,626,497.04
  无形资产摊销-4,913,701.81-9,740,074.75
  长期待摊费用摊销-43,225.92-214,408.32
  处置固定资产、无形资产和其他长期资产的损失--29,000.02--1,457,326.99
  固定资产报废损失-1,386,127.28-168,512.41
  公允价值变动损失-3,955,949.53--9,273,528.3
  财务费用-60,167,537.11-90,825,719.52
  投资损失--8,382,074.23--46,353,968.87
  递延所得税-3,698,339.21-8,424,746.1
  其中:递延所得税资产减少-4,760,677.78-1,609,208.12
    递延所得税负债增加--1,062,338.57-6,815,537.98
  存货的减少-991,295,168.63--391,834,718.99
  经营性应收项目的减少-105,811,032.28--8,244,979.44
  经营性应付项目的增加--218,725,745.65--31,405,046.97
  现金的期末余额-957,598,800.01-785,040,710.5
  减:现金的期初余额-785,040,710.5-514,802,240.02
  现金及现金等价物的净增加额-172,558,089.51-270,238,470.48
公告日期2026-10-272026-08-252026-04-252026-03-31
审计意见(境内)标准无保留意见
TOP↑